Aerobic training in patients with anoctamin 5 myopathy and hyperckemia

Christoffer R Vissing, Nicolai Preisler, Edith Husu, Kira P Prahm, John Vissing

16 Citationer (Scopus)

Abstract

INTRODUCTION: Anoctamin 5 deficiency has recently been defined to cause limb-girdle muscular dystrophy type 2L (LGMD2L) with pronounced hyperCKemia. No treatment interventions have been made so far in this condition.

METHODS: In 6 patients with LGMD2L, we studied the effect of home-based, pulse-watch monitored, moderate-intensity exercise on a cycle ergometer for 30 minutes, 3 times weekly, for 10 weeks. Plasma creatine kinase (CK) was assessed before, during, and after the program as a marker of muscle damage. Primary outcome measures were maximum oxygen uptake (VO(2max)) and time in the 5-repetitions-sit-to-stand test (FRSTST).

RESULTS: Training resulted in improvements in VO(2max) (27 ± 7%; P = 0.0001) and FRSTST time (35 ± 12%; P = 0.007). Improvements in physiologic and functional muscle testing were accompanied by stable CK levels and no reports of adverse effects.

CONCLUSIONS: These findings suggest that supervised aerobic exercise training is safe and effective in improving oxidative capacity and muscle function in patients with anoctamin 5 deficiency.

OriginalsprogEngelsk
TidsskriftMuscle & Nerve
Vol/bind50
Udgave nummer1
Sider (fra-til)119-123
Antal sider5
ISSN0148-639X
DOI
StatusUdgivet - jul. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Aerobic training in patients with anoctamin 5 myopathy and hyperckemia'. Sammen danner de et unikt fingeraftryk.

Citationsformater